Riskpilot← Back to searchSign inGet full accessCURA AS
ASActiveOrg 899619382Fyrstikkalléen 19, 0661 OsloOther human health activities n.e.c. · NACE 8699Est. 20130 employees
Revenue 2024
NOK 0
EBITDA margin
—
-1652% vs 2023
Equity ratio
89.9%
Financial strength
Net profit 2024
NOK -1,6M
-267% vs 2023
| Revenue | NOK 0 | — |
| EBITDA | NOK -2,1M | -1652% |
| Net profit | NOK -1,6M | -267% |
| Total assets | NOK 5,9M | +6% |
| Equity | NOK 5,3M | +4% |
| Employees | 0 | — |
Legal name
CURA AS
Org number
899619382
Legal form
Aksjeselskap
NACE code
8699 · Other human health activities n.e.c.
Founded
30. januar 2013
Share capital
NOK 100 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
To styremedlemmer i fellesskap.
Company purpose
Pleie og omsorgstjenester, samt annen virksomhet som naturlig faller sammen med dette, herunder deltakelse i andre selskaper.
Address
Fyrstikkalléen 19, 0661 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 3 762 | 5 576 | 28 590 | 29 871 | 26 344 | 22 872 | 35 231 | 31 851 | 13 092 | 90 | 0 |
| Staff expenses | −0 | −3 838 | −3 900 | −9 695 | −12 792 | −15 396 | −13 453 | −15 015 | −18 099 | −14 044 | 407 | −69 |
| EBITDA | −13 | −10 134 | −8 753 | 2 916 | 625 | −1 124 | 1 706 | 5 997 | −3 237 | −9 725 | −121 | −2 123 |
| Depreciation & amort. | −0 | −100 | −104 | −139 | −277 | −319 | −261 | −323 | −291 | −213 | −80 | −21 |
| EBIT | −13 | −10 234 | −8 857 | 2 777 | 348 | −1 443 | 1 445 | 5 674 | −3 528 | −9 938 | −202 | −2 144 |
| Net financials | 0 | −0 | −2 | −1 | 0 | 186 | 499 | 12 | −36 | −106 | −340 | 156 |
| Profit before tax | −13 | −10 235 | −8 859 | 2 776 | 348 | −1 256 | 1 944 | 5 686 | −3 564 | −10 043 | −542 | −1 988 |
| Tax | −0 | −2 197 | −1 433 | 850 | 152 | −263 | 432 | 1 257 | −782 | −2 200 | −119 | −437 |
| Net profit | −13 | −8 038 | −7 427 | 1 926 | 196 | −993 | 1 513 | 4 428 | −2 782 | −7 843 | −422 | −1 550 |
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 100 | 12 139 | 11 959 | 13 216 | 22 789 | 15 098 | 18 517 | 25 004 | 12 420 | 10 648 | 5 579 | 5 902 |
| Equity | 87 | 1 000 | 1 000 | 6 441 | 11 110 | 11 505 | 11 431 | 5 147 | 4 872 | 5 261 | 5 117 | 5 307 |
| Long-term debt | 0 | 9 946 | 10 168 | 4 327 | 753 | 983 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 13 | 1 192 | 791 | 2 448 | 10 926 | 2 609 | 7 086 | 19 489 | 7 276 | 5 202 | 55 | 420 |
| Total debt | 13 | 11 139 | 10 959 | 6 775 | 11 679 | 3 592 | 7 086 | 19 489 | 7 276 | 5 202 | 55 | 420 |
EBITDA margin
-212328400.0%
This company
15.8%
Market median
-1343850733% vs market
20132024
Equity ratio
89.9%
This company
38.2%
Market median
+135% vs market
20132024
Return on equity
-29.2%
This company
18.4%
Market median
-259% vs market
20132024
Net profit margin
-155047100.0%
This company
8.1%
Market median
-1914161828% vs market
20132024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20132024
Debt / equity
0.11×
This company
0.62×
Market median
+82% vs market
20132024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via Brønnøysundsregistrene · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via Brønnøysundsregistrene · Period 2013-01-01 – 2013-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
EM Chief Executive Officer | Chief Executive Officer | 2021 | — | — |
HM Chief Executive Officer | Chief Executive Officer | 2022 | — | — |
VJ Chief Executive Officer | Chief Executive Officer | 2024 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2023 | — | — | |
| Chairman | 2023 | — | — | |
| Chairman | 2023 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Unicare Helsepartner As | Company | 100.0% | 100.0% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Unicare As
CURA AS Board members of CURA AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Eun Maria Rabben Bertelsen | Chief Executive Officer | 0 companies |
| Hilde Merete Blikstad | Chief Executive Officer | 0 companies |
| Vidar Johansen | Chief Executive Officer | 0 companies |
| Trine Sjøvold | Board of Directors | 0 companies |
| Knut Øversjøen | Board of Directors | 0 companies |
| Lars Erik Baustad | Chairman | 0 companies |
| Ole Mjåtvedt | Chairman | 0 companies |